The global market for Diabetes Therapy and Drug Delivery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Diabetes Therapy and Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Therapy and Drug Delivery.

The Diabetes Therapy and Drug Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetes Therapy and Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diabetes Therapy and Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diabetes Therapy and Drug Delivery Market Report

Report Metric	Details
Report Name	Diabetes Therapy and Drug Delivery Market
CAGR	5%
Segment by Type	Inhalable Insulin Oral Insulin Insulin Patches CGM Systems Artificial Pancreas
Segment by Application	Diagnostic/Clinics ICUs Home Healthcare
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Medtronic, Sanofi, Novo Nordisk, MannKind, Enteris BioPharma, Dexcom, Senseonics Holding, Medtech, Johnson & Johnson, Synertech, Zosano Pharma, Relmada Therapeutics, Eli Lilly, Transdermal Specialties
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Therapy and Drug Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Diabetes Therapy and Drug Delivery Market report?

Ans: The main players in the Diabetes Therapy and Drug Delivery Market are Abbott Laboratories, Medtronic, Sanofi, Novo Nordisk, MannKind, Enteris BioPharma, Dexcom, Senseonics Holding, Medtech, Johnson & Johnson, Synertech, Zosano Pharma, Relmada Therapeutics, Eli Lilly, Transdermal Specialties

What are the Application segmentation covered in the Diabetes Therapy and Drug Delivery Market report?

Ans: The Applications covered in the Diabetes Therapy and Drug Delivery Market report are Diagnostic/Clinics, ICUs, Home Healthcare

What are the Type segmentation covered in the Diabetes Therapy and Drug Delivery Market report?

Ans: The Types covered in the Diabetes Therapy and Drug Delivery Market report are Inhalable Insulin, Oral Insulin, Insulin Patches, CGM Systems, Artificial Pancreas

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Inhalable Insulin

1.2.3 Oral Insulin

1.2.4 Insulin Patches

1.2.5 CGM Systems

1.2.6 Artificial Pancreas

1.3 Market by Application

1.3.1 Global Diabetes Therapy and Drug Delivery Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Diagnostic/Clinics

1.3.3 ICUs

1.3.4 Home Healthcare

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diabetes Therapy and Drug Delivery Market Perspective (2020-2031)

2.2 Global Diabetes Therapy and Drug Delivery Growth Trends by Region

2.2.1 Global Diabetes Therapy and Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Diabetes Therapy and Drug Delivery Historic Market Size by Region (2020-2025)

2.2.3 Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2026-2031)

2.3 Diabetes Therapy and Drug Delivery Market Dynamics

2.3.1 Diabetes Therapy and Drug Delivery Industry Trends

2.3.2 Diabetes Therapy and Drug Delivery Market Drivers

2.3.3 Diabetes Therapy and Drug Delivery Market Challenges

2.3.4 Diabetes Therapy and Drug Delivery Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diabetes Therapy and Drug Delivery Players by Revenue

3.1.1 Global Top Diabetes Therapy and Drug Delivery Players by Revenue (2020-2025)

3.1.2 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2020-2025)

3.2 Global Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Diabetes Therapy and Drug Delivery Revenue

3.4 Global Diabetes Therapy and Drug Delivery Market Concentration Ratio

3.4.1 Global Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetes Therapy and Drug Delivery Revenue in 2024

3.5 Global Key Players of Diabetes Therapy and Drug Delivery Head office and Area Served

3.6 Global Key Players of Diabetes Therapy and Drug Delivery, Product and Application

3.7 Global Key Players of Diabetes Therapy and Drug Delivery, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetes Therapy and Drug Delivery Breakdown Data by Type

4.1 Global Diabetes Therapy and Drug Delivery Historic Market Size by Type (2020-2025)

4.2 Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2026-2031)

5 Diabetes Therapy and Drug Delivery Breakdown Data by Application

5.1 Global Diabetes Therapy and Drug Delivery Historic Market Size by Application (2020-2025)

5.2 Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Diabetes Therapy and Drug Delivery Market Size (2020-2031)

6.2 North America Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Diabetes Therapy and Drug Delivery Market Size by Country (2020-2025)

6.4 North America Diabetes Therapy and Drug Delivery Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diabetes Therapy and Drug Delivery Market Size (2020-2031)

7.2 Europe Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Diabetes Therapy and Drug Delivery Market Size by Country (2020-2025)

7.4 Europe Diabetes Therapy and Drug Delivery Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size (2020-2031)

8.2 Asia-Pacific Diabetes Therapy and Drug Delivery Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region (2020-2025)

8.4 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Diabetes Therapy and Drug Delivery Market Size (2020-2031)

9.2 Latin America Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2020-2025)

9.4 Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size (2020-2031)

10.2 Middle East & Africa Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2020-2025)

10.4 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Diabetes Therapy and Drug Delivery Introduction

11.1.4 Abbott Laboratories Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.1.5 Abbott Laboratories Recent Development

11.2 Medtronic

11.2.1 Medtronic Company Details

11.2.2 Medtronic Business Overview

11.2.3 Medtronic Diabetes Therapy and Drug Delivery Introduction

11.2.4 Medtronic Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.2.5 Medtronic Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Diabetes Therapy and Drug Delivery Introduction

11.3.4 Sanofi Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.3.5 Sanofi Recent Development

11.4 Novo Nordisk

11.4.1 Novo Nordisk Company Details

11.4.2 Novo Nordisk Business Overview

11.4.3 Novo Nordisk Diabetes Therapy and Drug Delivery Introduction

11.4.4 Novo Nordisk Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.4.5 Novo Nordisk Recent Development

11.5 MannKind

11.5.1 MannKind Company Details

11.5.2 MannKind Business Overview

11.5.3 MannKind Diabetes Therapy and Drug Delivery Introduction

11.5.4 MannKind Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.5.5 MannKind Recent Development

11.6 Enteris BioPharma

11.6.1 Enteris BioPharma Company Details

11.6.2 Enteris BioPharma Business Overview

11.6.3 Enteris BioPharma Diabetes Therapy and Drug Delivery Introduction

11.6.4 Enteris BioPharma Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.6.5 Enteris BioPharma Recent Development

11.7 Dexcom

11.7.1 Dexcom Company Details

11.7.2 Dexcom Business Overview

11.7.3 Dexcom Diabetes Therapy and Drug Delivery Introduction

11.7.4 Dexcom Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.7.5 Dexcom Recent Development

11.8 Senseonics Holding

11.8.1 Senseonics Holding Company Details

11.8.2 Senseonics Holding Business Overview

11.8.3 Senseonics Holding Diabetes Therapy and Drug Delivery Introduction

11.8.4 Senseonics Holding Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.8.5 Senseonics Holding Recent Development

11.9 Medtech

11.9.1 Medtech Company Details

11.9.2 Medtech Business Overview

11.9.3 Medtech Diabetes Therapy and Drug Delivery Introduction

11.9.4 Medtech Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.9.5 Medtech Recent Development

11.10 Johnson & Johnson

11.10.1 Johnson & Johnson Company Details

11.10.2 Johnson & Johnson Business Overview

11.10.3 Johnson & Johnson Diabetes Therapy and Drug Delivery Introduction

11.10.4 Johnson & Johnson Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.10.5 Johnson & Johnson Recent Development

11.11 Synertech

11.11.1 Synertech Company Details

11.11.2 Synertech Business Overview

11.11.3 Synertech Diabetes Therapy and Drug Delivery Introduction

11.11.4 Synertech Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.11.5 Synertech Recent Development

11.12 Zosano Pharma

11.12.1 Zosano Pharma Company Details

11.12.2 Zosano Pharma Business Overview

11.12.3 Zosano Pharma Diabetes Therapy and Drug Delivery Introduction

11.12.4 Zosano Pharma Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.12.5 Zosano Pharma Recent Development

11.13 Relmada Therapeutics

11.13.1 Relmada Therapeutics Company Details

11.13.2 Relmada Therapeutics Business Overview

11.13.3 Relmada Therapeutics Diabetes Therapy and Drug Delivery Introduction

11.13.4 Relmada Therapeutics Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.13.5 Relmada Therapeutics Recent Development

11.14 Eli Lilly

11.14.1 Eli Lilly Company Details

11.14.2 Eli Lilly Business Overview

11.14.3 Eli Lilly Diabetes Therapy and Drug Delivery Introduction

11.14.4 Eli Lilly Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.14.5 Eli Lilly Recent Development

11.15 Transdermal Specialties

11.15.1 Transdermal Specialties Company Details

11.15.2 Transdermal Specialties Business Overview

11.15.3 Transdermal Specialties Diabetes Therapy and Drug Delivery Introduction

11.15.4 Transdermal Specialties Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025)

11.15.5 Transdermal Specialties Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Transdermal Specialties

List of Tables

Table 1. Global Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Inhalable Insulin

Table 3. Key Players of Oral Insulin

Table 4. Key Players of Insulin Patches

Table 5. Key Players of CGM Systems

Table 6. Key Players of Artificial Pancreas

Table 7. Global Diabetes Therapy and Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Diabetes Therapy and Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Diabetes Therapy and Drug Delivery Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Diabetes Therapy and Drug Delivery Market Share by Region (2020-2025)

Table 11. Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Diabetes Therapy and Drug Delivery Market Share by Region (2026-2031)

Table 13. Diabetes Therapy and Drug Delivery Market Trends

Table 14. Diabetes Therapy and Drug Delivery Market Drivers

Table 15. Diabetes Therapy and Drug Delivery Market Challenges

Table 16. Diabetes Therapy and Drug Delivery Market Restraints

Table 17. Global Diabetes Therapy and Drug Delivery Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Diabetes Therapy and Drug Delivery Market Share by Players (2020-2025)

Table 19. Global Top Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Therapy and Drug Delivery as of 2024)

Table 20. Ranking of Global Top Diabetes Therapy and Drug Delivery Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Diabetes Therapy and Drug Delivery Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Diabetes Therapy and Drug Delivery, Headquarters and Area Served

Table 23. Global Key Players of Diabetes Therapy and Drug Delivery, Product and Application

Table 24. Global Key Players of Diabetes Therapy and Drug Delivery, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Diabetes Therapy and Drug Delivery Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2020-2025)

Table 28. Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2026-2031)

Table 30. Global Diabetes Therapy and Drug Delivery Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2020-2025)

Table 32. Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2026-2031)

Table 34. North America Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Diabetes Therapy and Drug Delivery Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Diabetes Therapy and Drug Delivery Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Diabetes Therapy and Drug Delivery Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Diabetes Therapy and Drug Delivery Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2026-2031) & (US$ Million)

Table 49. Abbott Laboratories Company Details

Table 50. Abbott Laboratories Business Overview

Table 51. Abbott Laboratories Diabetes Therapy and Drug Delivery Product

Table 52. Abbott Laboratories Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 53. Abbott Laboratories Recent Development

Table 54. Medtronic Company Details

Table 55. Medtronic Business Overview

Table 56. Medtronic Diabetes Therapy and Drug Delivery Product

Table 57. Medtronic Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 58. Medtronic Recent Development

Table 59. Sanofi Company Details

Table 60. Sanofi Business Overview

Table 61. Sanofi Diabetes Therapy and Drug Delivery Product

Table 62. Sanofi Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 63. Sanofi Recent Development

Table 64. Novo Nordisk Company Details

Table 65. Novo Nordisk Business Overview

Table 66. Novo Nordisk Diabetes Therapy and Drug Delivery Product

Table 67. Novo Nordisk Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 68. Novo Nordisk Recent Development

Table 69. MannKind Company Details

Table 70. MannKind Business Overview

Table 71. MannKind Diabetes Therapy and Drug Delivery Product

Table 72. MannKind Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 73. MannKind Recent Development

Table 74. Enteris BioPharma Company Details

Table 75. Enteris BioPharma Business Overview

Table 76. Enteris BioPharma Diabetes Therapy and Drug Delivery Product

Table 77. Enteris BioPharma Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 78. Enteris BioPharma Recent Development

Table 79. Dexcom Company Details

Table 80. Dexcom Business Overview

Table 81. Dexcom Diabetes Therapy and Drug Delivery Product

Table 82. Dexcom Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 83. Dexcom Recent Development

Table 84. Senseonics Holding Company Details

Table 85. Senseonics Holding Business Overview

Table 86. Senseonics Holding Diabetes Therapy and Drug Delivery Product

Table 87. Senseonics Holding Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 88. Senseonics Holding Recent Development

Table 89. Medtech Company Details

Table 90. Medtech Business Overview

Table 91. Medtech Diabetes Therapy and Drug Delivery Product

Table 92. Medtech Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 93. Medtech Recent Development

Table 94. Johnson & Johnson Company Details

Table 95. Johnson & Johnson Business Overview

Table 96. Johnson & Johnson Diabetes Therapy and Drug Delivery Product

Table 97. Johnson & Johnson Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 98. Johnson & Johnson Recent Development

Table 99. Synertech Company Details

Table 100. Synertech Business Overview

Table 101. Synertech Diabetes Therapy and Drug Delivery Product

Table 102. Synertech Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 103. Synertech Recent Development

Table 104. Zosano Pharma Company Details

Table 105. Zosano Pharma Business Overview

Table 106. Zosano Pharma Diabetes Therapy and Drug Delivery Product

Table 107. Zosano Pharma Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 108. Zosano Pharma Recent Development

Table 109. Relmada Therapeutics Company Details

Table 110. Relmada Therapeutics Business Overview

Table 111. Relmada Therapeutics Diabetes Therapy and Drug Delivery Product

Table 112. Relmada Therapeutics Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 113. Relmada Therapeutics Recent Development

Table 114. Eli Lilly Company Details

Table 115. Eli Lilly Business Overview

Table 116. Eli Lilly Diabetes Therapy and Drug Delivery Product

Table 117. Eli Lilly Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 118. Eli Lilly Recent Development

Table 119. Transdermal Specialties Company Details

Table 120. Transdermal Specialties Business Overview

Table 121. Transdermal Specialties Diabetes Therapy and Drug Delivery Product

Table 122. Transdermal Specialties Revenue in Diabetes Therapy and Drug Delivery Business (2020-2025) & (US$ Million)

Table 123. Transdermal Specialties Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

Table 127. Authors List of This Report

List of Figures

Figure 1. Diabetes Therapy and Drug Delivery Picture

Figure 2. Global Diabetes Therapy and Drug Delivery Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Diabetes Therapy and Drug Delivery Market Share by Type: 2024 VS 2031

Figure 4. Inhalable Insulin Features

Figure 5. Oral Insulin Features

Figure 6. Insulin Patches Features

Figure 7. CGM Systems Features

Figure 8. Artificial Pancreas Features

Figure 9. Global Diabetes Therapy and Drug Delivery Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Diabetes Therapy and Drug Delivery Market Share by Application: 2024 VS 2031

Figure 11. Diagnostic/Clinics Case Studies

Figure 12. ICUs Case Studies

Figure 13. Home Healthcare Case Studies

Figure 14. Diabetes Therapy and Drug Delivery Report Years Considered

Figure 15. Global Diabetes Therapy and Drug Delivery Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Diabetes Therapy and Drug Delivery Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Diabetes Therapy and Drug Delivery Market Share by Region: 2024 VS 2031

Figure 18. Global Diabetes Therapy and Drug Delivery Market Share by Players in 2024

Figure 19. Global Top Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Therapy and Drug Delivery as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Diabetes Therapy and Drug Delivery Revenue in 2024

Figure 21. North America Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Diabetes Therapy and Drug Delivery Market Share by Country (2020-2031)

Figure 23. United States Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Diabetes Therapy and Drug Delivery Market Share by Country (2020-2031)

Figure 27. Germany Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Diabetes Therapy and Drug Delivery Market Share by Region (2020-2031)

Figure 35. China Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Diabetes Therapy and Drug Delivery Market Share by Country (2020-2031)

Figure 43. Mexico Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Diabetes Therapy and Drug Delivery Market Share by Country (2020-2031)

Figure 47. Turkey Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Diabetes Therapy and Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Abbott Laboratories Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 51. Medtronic Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 52. Sanofi Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 53. Novo Nordisk Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 54. MannKind Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 55. Enteris BioPharma Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 56. Dexcom Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 57. Senseonics Holding Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 58. Medtech Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 59. Johnson & Johnson Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 60. Synertech Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 61. Zosano Pharma Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 62. Relmada Therapeutics Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 63. Eli Lilly Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 64. Transdermal Specialties Revenue Growth Rate in Diabetes Therapy and Drug Delivery Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions